EisnerAmper Wealth Management Corporate Benefits’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
IC
EisnerAmper Wealth Management Corporate Benefits's NVS Position: Q4 2015 in Review
EisnerAmper Wealth Management Corporate Benefits sold out of Novartis (NVS) in Q4 2015, closing a stake of 14,939 shares — an estimated $1.23M sold.
EisnerAmper Wealth Management Corporate Benefits first reported a position in NVS in Q4 2014 and held it in 4 quarters. The position peaked at $1.42M in Q1 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.
- EisnerAmper Wealth Management Corporate Benefits reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
- EisnerAmper Wealth Management Corporate Benefits sold 14,939 Novartis shares in Q4 2015, an estimated $1.23M.
- EisnerAmper Wealth Management Corporate Benefits first reported a position in Novartis in Q4 2014 and held it in 4 quarters.
- EisnerAmper Wealth Management Corporate Benefits's Novartis position peaked at $1.42M in Q1 2015.
- 926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.
Based on EisnerAmper Wealth Management Corporate Benefits's 13F filing for Q4 2015, filed 4 Jan 2016.